Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data

Managing risks in drug discovery: reproducibility of published findings

(2016) Aimo Kannt et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data

(2015) Irawati Kandela et al.   eLife

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

Standardised animal models of host microbial mutualism

(2014) A J Macpherson et al.   Mucosal Immunology

Policy: NIH to balance sex in cell and animal studies

(2014) Janine A. Clayton et al.   NATURE

An open investigation of the reproducibility of cancer biology research

(2014) Timothy M Errington et al.   eLife

Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer

(2013) Swati Biswas et al.   CANCER LETTERS

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

(2013) Hongbo Wang et al.   Evidence-based Complementary and Alternative Medicine

Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature

(2013) K. M. Kokolus et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo

(2012) Nam Kim   INTERNATIONAL JOURNAL OF ONCOLOGY

Cimetidine: An anticancer drug?

(2011) Martina Kubecova et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

(2011) M. Sirota et al.   Science Translational Medicine

TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In vivo

(2010) S. Wang et al.   CLINICAL CANCER RESEARCH

Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma

(2009) G. Lopez et al.   CLINICAL CANCER RESEARCH